Dr. Omid Farokhzad, Chair, CEO and Founder of Seer, sits down to discuss how Seer\u2019s cutting edge work with protein and proteomics is removing technological barriers and providing scientists with better tools to make breakthroughs than ever before.\nDr. Farokhzad and host of #ThePlaybook, David Meltzer, chat about a range of topics including the markets that will most benefit from proteomics and why Dr. Farokhzad says their company\u2019s future goal is the diagnosis of disease at the pre-symptomatic level. The pair also share their thoughts on how Seer\u2019s initial public offering in 2020 has impacted the way that the organization is run.